Cutaneous inflammation in the DIAMOND™ mouse model of non-alcoholic fatty liver disease

被引：0
|
作者：
Enos, C. [1 ]
Van Voorhees, A. S. [1 ]
Marioneaux, J. [2 ]
Sanyal, A. [2 ]
Caffrey, R. [2 ]
机构：
[1] Eastern Virginia Med Sch, Dermatol, Norfolk, VA 23501 USA
[2] Sanyal Biotechnol, Norfolk, VA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
491
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] A human liver chimeric mouse model for non-alcoholic fatty liver disease
    Bissig-Choisat, Beatrice
    Alves-Bezerra, Michele
    Zorman, Barry
    Ochsner, Scott A.
    Barzi, Mercedes
    Legras, Xavier
    Yang, Diane
    Borowiak, Malgorzata
    Dean, Adam M.
    York, Robert B.
    Galvan, N. Thao N.
    Goss, John
    Lagor, William R.
    Moore, David D.
    Cohen, David E.
    McKenna, Neil J.
    Sumazin, Pavel
    Bissig, Karl-Dimiter
    [J]. JHEP REPORTS, 2021, 3 (03)
  • [2] Insulin resistance, inflammation, and non-alcoholic fatty liver disease
    Tilg, Herbert
    Moschen, Alexander R.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (10): : 371 - 379
  • [3] Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease
    Gaemers, Ingrid C.
    Stallen, Jan M.
    Kunne, Cindy
    Wallner, Christian
    van Werven, Jochem
    Nederveen, Aart
    Lamers, Wouter H.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (04): : 447 - 458
  • [4] Treating inflammation to combat non-alcoholic fatty liver disease
    Wiering, Leke
    Tacke, Frank
    [J]. JOURNAL OF ENDOCRINOLOGY, 2023, 256 (01)
  • [5] Effects of thermoneutral housing in a mouse model of non-alcoholic fatty liver disease
    Martin, C. M. P.
    Polizzi, A.
    Alquier-Bacquie, V.
    Laserre, F.
    Huillet, M.
    Rives, C.
    Bertrand-Michel, J.
    Lippi, Y.
    Lotersztajn, S.
    Gamet-Payrastre, L.
    Guillou, H.
    Ellero-Simatos, S.
    Fougerat, A.
    Loiseau, N.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S513 - S514
  • [6] Metabolic Adaptations in the Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model
    Kahle, Melanie
    Leonhardt, Joern
    Fridrich, Barbara
    Harts-Perger, Mara
    Stuempflen, Volker
    Irmler, Martin
    Beckers, Johannes
    Mewes, Hans-Werner
    De Angelis, Martin Hrabe
    Neschen, Susanne
    [J]. DIABETES, 2011, 60 : A684 - A684
  • [7] Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model
    Lu, Yulei
    Lin, Youzhi
    Huang, Xiaoqing
    Wu, Shengming
    Wei, Jian
    Yang, Chun
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (06) : 2398 - 2408
  • [8] An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Marin, Veronica
    Rosso, Natalia
    Dal Ben, Matteo
    Raseni, Alan
    Boschelle, Manuela
    Degrassi, Cristina
    Nemeckova, Ivana
    Nachtigal, Petr
    Avellini, Claudio
    Tiribelli, Claudio
    Gazzin, Silvia
    [J]. PLOS ONE, 2016, 11 (07):
  • [9] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [10] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
12345